The study also looked at how many people maintained at least 80% of the weight loss after the initial 36 weeks, and while many more who continued on the drug did almost 90% - almost 17% of people who were switched to a placebo maintained that much weight loss without the drug
38: 123 Feldman EL, Stevens MJ, Thomas PK, et al
FIDELIO was quite different, with carefully chosen eligibility criteria making sure only patients at high risk of clinical outcomes but lower risk of adverse events, a run-in period to weed out participants at high risk of hyperkalemia, liberal use of K binders to maintain participants on finerenone
Mild swelling or redness at the injection site
[Multipurpose psyllium monotherapy in patients with diverticular disease]
Each operates under different regulatory frameworks with different implications for quality, legality, and safety